Autoimmune rheumatic diseases: recent advances and current challenges

Flavia M Cicuttini
Med J Aust 2017; 206 (5): . || doi: 10.5694/mja17.00047
Published online: 20 March 2017

Biological disease-modifying agents are transforming the treatment of autoimmune rheumatic diseases

Over the past decade, the advent of biological disease-modifying agents has led to transformational changes in the management of inflammatory joint diseases. This has been most obvious with advances in treatments for rheumatoid arthritis (RA). However, steady progress is also being made in treating lupus and other autoimmune rheumatic conditions. In this issue of the MJA, several articles discuss these developments along with current challenges.

  • Flavia M Cicuttini

  • Monash University, Melbourne, VIC


Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.